Assignee
NANSHA BIOLOGICS HONG KONG LTD
HK·4 granted patents·0 citations·filing 2016–2021
Top patents by PatentIndex Score
4 records- 0170US11931417B2Methods of preparing a pegylated human IL-11 compositionNANSHA BIOLOGICS HONG KONG LTD·Filed 2021·Granted Mar 19, 2024·0 cites·8 claims
- 0266US10946103B2Methods of treatment using a branched amino terminal pegylated Il-11 compositionNANSHA BIOLOGICS HONG KONG LTD·Filed 2019·Granted Mar 16, 2021·0 cites·7 claims
- 0366US10881739B2Interleukin-11 PEGylation reaction intermediate compositionNANSHA BIOLOGICS HONG KONG LTD·Filed 2019·Granted Jan 5, 2021·0 cites·7 claims
- 0453US10335492B2Increasing serum half-life of human IL-11 variants by N-terminal branched PEGylationNANSHA BIOLOGICS HONG KONG LTD·Filed 2016·Granted Jul 2, 2019·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when NANSHA BIOLOGICS HONG KONG LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →